The most profound and well-studied paradigm in hematology is the AML subtype, which carries mutations in the nucleophosmin1 gene (NPM1) that direct nucleophosmin1 molecule to translocate in the cytoplasm, possibly misrouting other molecules and altering various gene regulatory networks in both compartments [10]. The gene discussed is NPM1; the disease is acute myeloid leukemia.